Moderna Secures $590M Funding From U.S. Government for Bird Flu Jab
Portfolio Pulse from
Moderna has secured $590 million in funding from the U.S. government to develop an mRNA-based bird flu vaccine and expand clinical studies for other pandemic influenza subtypes.
January 20, 2025 | 3:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Moderna has received $590 million in funding from the U.S. government to develop a bird flu vaccine using mRNA technology and to expand clinical studies for other influenza subtypes.
The significant funding from the U.S. government is a strong endorsement of Moderna's mRNA technology and its potential in addressing pandemic influenza. This financial support is likely to accelerate the development of new vaccines, potentially leading to future revenue streams and strengthening Moderna's position in the vaccine market.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100